Accordingly, the PP1/GSK3β signaling cascade downstream of PAD exposure would be expected to directly target a subset of anterograde FAT cargoes transported by conventional kinesin isoforms containing KLC2. The gene discussed is KLC2; the disease is peripheral arterial disease.